| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Operating costs and expenses | ||||||
Research and development | ||||||
2,025 | 785 | |||||
Research and development - licenses acquired (including stock-based compensation) | ||||||
95 | 230 | |||||
Compensation and related expenses (including stock-based compensation) | ||||||
2,932 | 509 | |||||
Professional fees (including stock-based compensation) | ||||||
2,091 | 682 | |||||
Rent | ||||||
31 | 28 | |||||
Other expenses | ||||||
538 | 258 | |||||
Total operating expenses | ||||||
7,714 | 2,495 | |||||
Loss from operations | ||||||
-7,714 | -2,495 | |||||
Other expenses | ||||||
Other expense, net | ||||||
10 | - | |||||
Loss on foreign currency exchange | ||||||
-0 | - | |||||
Total other expenses | ||||||
10 | - | |||||
Net loss | ||||||
-7,704 | -2,495 | |||||
Weighted average number of common shares outstanding, basic and diluted | ||||||
9,164 | 5,031 | |||||
Net loss per share, basic and diluted | ||||||
-0.84 | -0.50 | |||||